CUTANEOUS LYMPHOMA

CUTANEOUS LYMPHOMA was reported 204 times

CUTANEOUS LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Chemokine Receptor Type 4 Interaction [EPC] 2 0.0015
1 Interleukin-5 Antagonist [EPC] 1 0.0015
2 Interleukin-17 Receptor A Antagonist [EPC] 2 0.0010
3 Interleukin-17A Antagonist [EPC] 17 0.0005
4 CD30-directed Immunoconjugate [EPC] 4 0.0004
5 Histone Deacetylase Inhibitor [EPC] 1 0.0003
6 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
7 Janus Kinase Inhibitor [EPC] 25 0.0002
8 Dopamine-2 Receptor Antagonist [EPC] 1 0.0001
9 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
10 Interleukin-23 Antagonist [EPC] 10 0.0001
11 Folate Analog Metabolic Inhibitor [EPC] 33 0.0001
12 Calcineurin Inhibitor Immunosuppressant [EPC] 9 0.0001
13 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
14 Purine Antimetabolite [EPC] 6 0.0001
15 Soluble Guanylate Cyclase Stimulator [EPC] 2 0.0001
16 Nitrofuran Antibacterial [EPC] 1 0.0001
17 Interleukin-6 Receptor Antagonist [EPC] 7 0.0001
18 Alkylating Drug [EPC] 12 0.0000
19 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
20 Human Immunoglobulin G [EPC] 1 0.0000
21 Interleukin-4 Receptor alpha Antagonist [EPC] 23 0.0000
22 Phosphodiesterase 4 Inhibitor [EPC] 7 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 13 0.0000
24 Aminosalicylate [EPC] 4 0.0000
25 Interleukin-12 Antagonist [EPC] 4 0.0000
26 Prostacyclin Receptor Agonist [EPC] 1 0.0000
27 Selective T Cell Costimulation Modulator [EPC] 5 0.0000
28 Integrin Receptor Antagonist [EPC] 3 0.0000
29 Anti-IgE [EPC] 3 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 34 0.0000
31 Provitamin D2 Compound [EPC] 1 0.0000
32 Estrogen [EPC] 6 0.0000
33 Angiotensin 2 Receptor Blocker [EPC] 10 0.0000
34 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
35 Topoisomerase Inhibitor [EPC] 2 0.0000
36 Aldosterone Antagonist [EPC] 4 0.0000
37 Thiazide-like Diuretic [EPC] 1 0.0000
38 Central Nervous System Stimulant [EPC] 2 0.0000
39 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
40 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
41 Corticosteroid [EPC] 23 0.0000
42 Parathyroid Hormone Analog [EPC] 2 0.0000
43 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
44 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
45 Kinase Inhibitor [EPC] 9 0.0000
46 Benzodiazepine [EPC] 11 0.0000
47 Antidote [EPC] 1 0.0000
48 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
49 Androgen Receptor Inhibitor [EPC] 1 0.0000
50 Retinoid [EPC] 3 0.0000
51 Nitrate Vasodilator [EPC] 1 0.0000
52 Insulin Analog [EPC] 5 0.0000
53 Platinum-based Drug [EPC] 3 0.0000
54 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
55 Factor Xa Inhibitor [EPC] 3 0.0000
56 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
57 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
58 Vitamin D [EPC] 3 0.0000
59 RANK Ligand Inhibitor [EPC] 2 0.0000
60 Vitamin C [EPC] 4 0.0000
61 Antirheumatic Agent [EPC] 1 0.0000
62 Vitamin B12 [EPC] 3 0.0000
63 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
64 Mood Stabilizer [EPC] 2 0.0000
65 Anti-epileptic Agent [EPC] 2 0.0000
66 Loop Diuretic [EPC] 4 0.0000
67 Proteasome Inhibitor [EPC] 1 0.0000
68 Thalidomide Analog [EPC] 4 0.0000
69 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
70 Leukocyte Growth Factor [EPC] 1 0.0000
71 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
72 Calcium [EPC] 1 0.0000
73 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
74 Endothelin Receptor Antagonist [EPC] 1 0.0000
75 GLP-1 Receptor Agonist [EPC] 2 0.0000
76 Osmotic Laxative [EPC] 1 0.0000
77 beta-Adrenergic Blocker [EPC] 1 0.0000
78 Platelet Aggregation Inhibitor [EPC] 1 0.0000